Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update
Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive safe ...
Alpha Tau Medical Ltd.: Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update
Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive safe ...
Artis REIT: 8.5% Yield On Preferreds Beats The Common
Artis Real Estate Investment Trust's Q4-2024 showed continued success with their deleveraging efforts. Learn more on AX.UN:CA ...
ASML: Thoughts On Valuing A Monopoly
ASML dominates the semiconductor lithography market, especially in EUV technology. Click here to read more about ASML stock ...